Biofrontera (NASDAQ:BFRI) just reported results for the first quarter of 2024.
- Biofrontera reported earnings per share of -$2.88. This was below the analyst estimate for EPS of -$1.17.
- The company reported revenue of $7.91 million.
- This was 27.15% worse than the analyst estimate for revenue of $10.86 million.